England's Access to New Publicly Funded Medicines Lags in Europe
A recent report indicates that England ranks seventh among 36 European nations regarding the availability of publicly funded new medicines. The study highlights challenges within the approval process, contributing to a decrease in the UK's access to medicines approved by the European Medicines Agency between 2021 and 2024. This suggests potential hurdles for patients seeking innovative treatments.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.